Media Centre

Featured Media Release
 

07 May 2014 - GSK encourages research excellence as award nominations open

GSK has opened nominations for what is regarded as one of the most prestigious research awards available to the Australian science community - the 2014 GSK Award for Research Excellence

 
 

Media Releases


Avandia (rosiglitazone maleate) - Australian Update

Following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration], each agency has today informed GlaxoSmithKline (GSK) of their individual regulatory decisions and resulting...

24/09/2010

 

Avandia (rosiglitazone maleate): GSK Australia spokesperson available post FDA Advisory Group Recommendation.

GlaxoSmithKline (GSK) Australia Medical Director, Dr Camilla Chong will be available to speak with Australian journalists about the outcome of the U.S. Food and Drug Administration (FDA) Advisory Committee recommendation in relation to the...

13/07/2010

 

ViiV Healthcare Lauched in Australia

New specialist HIV company dedicated to delivering advances in HIV treatment and care

04/11/2009

 

GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) announced that it has completed its acquisition of Stiefel

24/07/2009

< 3 4 5 6 7 8 9 10 11 12 13